We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RZLT market cap is 156.12M. The company's latest EPS is USD -1.3069 and P/E is -3.02.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.14M | -14.24M | -15.91M | -15.19M | -16.21M |
| Net Income | -15.67M | -12.73M | -14.52M | -13.91M | -17.05M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -25.93M | -20.52M | -22.89M | -41.84M | -55.99M |
| Net Income | -30.45M | -20.33M | -20.9M | -41.06M | -51.79M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 134.21M | 123.72M | 113M | 102.15M | 87.74M |
| Total Liabilities | 6.89M | 7.55M | 9.44M | 10.42M | 16.88M |
| Total Equity | 127.32M | 116.17M | 103.56M | 91.73M | 70.86M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.25M | 10.97M | 42.61M | 152.42M | 123.72M |
| Total Liabilities | 10.5M | 3.6M | 16.51M | 2.95M | 7.55M |
| Total Equity | 1.75M | 7.37M | 26.1M | 149.47M | 116.17M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.13M | -44.48M | -10.59M | -23.61M | -38.85M |
| Investing | -95.11M | -101.46M | 2.61M | 20.37M | 29.04M |
| Financing | 11.57M | 11.57M | N/A | -293k | -296k |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.3M | -24.17M | -20.44M | -39.62M | -44.48M |
| Investing | 231k | N/A | N/A | N/A | -101.46M |
| Financing | 25M | 22.55M | 51.53M | 148.98M | 11.57M |
| Market Cap | 156.12M |
| Price to Earnings Ratio | -3.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.76 |
| Price to Book Ratio | 1.35 |
| Dividend Yield | - |
| Shares Outstanding | 39.63M |
| Average Volume (1 week) | 600.94k |
| Average Volume (1 Month) | 1.27M |
| 52 Week Change | 87.61% |
| 52 Week High | 6.0999 |
| 52 Week Low | 0.72 |
| Spread (Intraday) | 1.44 (35.82%) |
| Company Name | Rezolute Inc |
| Address |
187 e warm springs road las vegas, nevada 89119 |
| Website | https://www.rezolutebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
